Online conference

SCHEDULE.

Medfuture Research Center - Iuliu Hatieganu University, 23 rd Marinescu Street

10:00 am – 02:00 pm Title: CA21135 – Immuno-model: Modelling immunotherapy response and toxicity in cancer  
5:00 pm – 7:00 pm Keynote Lecture - Aaron Ciechanover, Nobel Prize in Chemistry 2004  
08:30 am – 09:00 am Sorina Badelita, MD Fundeni Clinical Institute, Bucharest, Romania  
09:00 am – 09:30 am Gabriel Ghiaur, MD The Johns Hopkins University School
of Medicine, Baltimore, USA
AML non-promotional educational session
organized with the support of AbbVie
 
09:30 am – 10:00 am Jessica Altman, MD Feinman School of Medicine
Northwestern University, Chicago, USA
AML non-promotional educational session
organized with the support of AbbVie
 
10:00 am – 10:30 am : B. Douglad Smith, MD The Johns Hopkins University School of Medicine,
Baltimore, USA
 
10:30 am – 10:50 am : Janssen Romania Symposium  
10:50 am – 11:10 am : Janssen Romania Symposium  
11:10 am – 12:00 pm : Novartis Symposium
Florian Heidel M.D.
PV-AIM study presentation
 
12:00 pm – 12:30 pm : BMS symposiums
Ciprian Tomuleasa, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy,
Cluj-Napoca, Romania
INREBIC in terapia mielofibrozei
12:30 am – 1:00 pm : Lunch Break    
1:00 pm – 1:30 pm : Melody Smith, M.D. Stanford University, Stanford, USA  
1:30 pm – 2:00 pm : Eunice Wang, MD Roswell Park Comprehensive Cancer Center, USA  
2:00 pm – 2:20 pm : Janssen Romania Symposium  
2:20 pm – 2:40 pm : Janssen Romania Symposium  
2:30 pm – 3:00 pm : Laura Belver, Ph.D. Josep Carreras Leukemia Research Institute,
Barcelona, Spain
 
3:00 pm – 3:45 pm: Roche Symposiums
Anca Bojan, M.D.
Department of Hematology -
Oncological Institute "Prof. Dr. Ion Chiricută" Cluj-Napoca
Looking Beyond Bleeds:
What Else Is Important For Patients with HA?
Clinical outcomes with HEMLIBRA in the IOCN
Roche Symposiums
Moderator: Mihnea Zdrenghea M.D.
Speaker: Ciprian Tomuleasa M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy,
Cluj-Napoca, Romania
DLBCL. The opportunity of first-line treatment
3:00 pm – 3:30 pm: Accord symposiums
Horia Bumbea, M.D., Ph.D
Spitalul Universitar de Urgenta Bucuresti Impactul primei linii de tratament asupra rezultatului
procedurii de transplant in Mielom Multiplu
3:30 pm – 3:50 pm: Takeda Symposium
Ciprian Tomuleasa, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy,
Cluj-Napoca, Romania
3:50 pm – 4:10 pm: Takeda Symposiums
Delia Dima, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy,
Cluj-Napoca, Romania
4:10 pm – 4:40 pm: AstraZeneca symposiums  
4:40 pm – 5:00 pm : Takeda Symposiums
Ciprian Tomuleasa, M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy,
Cluj-Napoca, Romania
5:00 pm – 5:30 pm : AstraZeneca symposiums
Speaker: Ciprian Tomuleasa M.D.
 
5:30 pm – 5:50 pm : BMS symposiums
Mihnea Zdrenghea M.D.
Department of Hematology - Iuliu Hatieganu
University of Medicine and Pharmacy,
Cluj-Napoca, Romania
Maintenance in AML: Oral Azacitidine
5:50 pm – 6:50 pm : Genesis Pharma symposium  
6:50 pm – 7:20 pm : Hillard Lazarus, MD Editor in Chief – Blood Reviews  
8:30 pm - 09:00 am: Eric Oksenhendler, MD, Hôpital Saint-Louis, Paris, France  
9:00 pm - 09:30 am: Evangelos Terpos, MD School of Medicine, National
and Kapodistrian University of Athens
 
09:30 am – 10:30 am: Astellas symposium  
10:30 am – 11:00 am: Jaroslav Cermak, M.D. Institute of Hematology and Blood Transfusion,
Prague, Czech Republic
 
11:00 am – 11:30 am: Sebastian Kobold, MD
University of München, Germany
DLBCL non-promotional educational
session organized with the support of AbbVie
11:30 am – 12:00 am: Pfizer symposium  
12:00 pm – 12:30 pm: Pfizer symposium  
12:30 pm – 1:00 pm: Polina Stepensky, MD The Hebrew University of Jerusalem, Jerusalem, Israel  
1:00 pm – 1:15 pm: Sobi Symposium
Adina Trăilă, MD
„Cristian Șerban” Medical Assessment and Rehabilitation
Center for Children and Youth, Buziaș, Romania
Efmoroctocog alfa – Extended half-life FVIII in
clinical practice- one answer to multiple patients’ profiles
1:15 pm – 1:30 pm: Sobi Symposium
Ciprian Tomuleasa, MD
"Ion Chiricuta" The Oncology Institute
Cluj-Napoca, Romania
Unlocking New Potential:
Oral Therapy’s Swift and Sustained Effect
1:30 pm – 2:00 pm: LUNCH BREAK    
2:00 pm – 2:30 pm: Hermann Einsele, MD. Julius Maximilians University Würzburg, Germany  
2:30 pm – 2:45 pm: Sanofi symposium  
3:00 pm – 3:20 pm: Pfizer symposium  
3:20 pm – 3:40 pm: Pfizer symposium  
3:40 pm – 4:00 pm: Pfizer symposium  
4:00 pm – 4:30 pm: Erik Oksenhendler, M.D. Clinical Immunology at
Hopital Saint-Louis in Paris
Networking in very rare diseases.
French experience in Castleman disease
4:30 pm - 5:00 pm: AOP Orphan symposium
Ciprian Tomuleasa, M.D.
Department of Hematology -
Iuliu Hatieganu University of Medicine and
Pharmacy, Cluj-Napoca, Romania
 
5:00 pm - 5:30 pm: Jonatham Fromm, M.D. University of Washington, Seattle, USA  
5:30 -6:00 pm: Company symposiums  
06:00 pm: Closing remarks